The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 multi-institutional prospective feasibility study of uracil-tegafur and leucovorin as adjuvant chemotherapy for patients aged 80 years or more after curative resection of colorectal cancer: The HiSCO-03 study.
 
Masashi Miguchi
No Relationships to Disclose
 
Satoshi Ikeda
No Relationships to Disclose
 
Manabu Shimomura
No Relationships to Disclose
 
Masahiro Nakahara
No Relationships to Disclose
 
Tomohiro Adachi
No Relationships to Disclose
 
Yasuyo Ishizaki
No Relationships to Disclose
 
Yasufumi Saitoh
No Relationships to Disclose
 
Kazuhiro Toyota
No Relationships to Disclose
 
Daisuke Sumitani
No Relationships to Disclose
 
Yosuke Shimizu
No Relationships to Disclose
 
Yuji Takakura
No Relationships to Disclose
 
Wataru Shimizu
No Relationships to Disclose
 
Masanori Yoshimitsu
No Relationships to Disclose
 
Shinya Kodama
No Relationships to Disclose
 
Masahiko Fujimori
No Relationships to Disclose
 
Mamoru Oeda
No Relationships to Disclose
 
Hironori Kobayashi
No Relationships to Disclose
 
Hideki Ohdan
No Relationships to Disclose